首页 | 本学科首页   官方微博 | 高级检索  
     

晚期胰腺癌的内科治疗进展
引用本文:孔 颖,刘 磊,张婷婷,周建华. 晚期胰腺癌的内科治疗进展[J]. 现代肿瘤医学, 2015, 0(11): 1603-1606. DOI: 10.3969/j.issn.1672-4992.2015.11.39
作者姓名:孔 颖  刘 磊  张婷婷  周建华
作者单位:哈尔滨医科大学附属肿瘤医院内二科,黑龙江 哈尔滨 150081
基金项目:黑龙江省攻关课题(编号:GB06C40202)
摘    要:胰腺癌是恶性程度极高、预后极差的消化系统肿瘤。由于发现时多为晚期,因此化疗、放疗、靶向等内科治疗是目前晚期胰腺癌的主要治疗手段。以吉西他滨、氟尿嘧啶、铂类为基础的传统化疗在晚期胰腺癌治疗中疗效有限,白蛋白结合型紫杉醇、厄洛替尼、尼妥珠单抗等药物尚处于临床试验阶段。因此,寻求新的靶标及治疗手段显得尤为重要。本文就晚期胰腺癌的内科治疗进展作一综述。

关 键 词:胰腺癌  化疗  靶向治疗

The progress of medical therapy in advanced pancreatic cancer
Kong Ying,Liu Lei,Zhang Tingting,Zhou Jianhua. The progress of medical therapy in advanced pancreatic cancer[J]. Journal of Modern Oncology, 2015, 0(11): 1603-1606. DOI: 10.3969/j.issn.1672-4992.2015.11.39
Authors:Kong Ying  Liu Lei  Zhang Tingting  Zhou Jianhua
Affiliation:Department of Medical Oncology,The Tumor Hospital of Harbin Medical University,Heilongjiang Harbin 150081,China.
Abstract:Pancreatic cancer is an aggressive disease and have a very worse prognosis in all gastrointestinal tumors.Chemotherapy radiotherapy and biological targeted therapy are main treatments for advanced pancreatic cancer.It has achieved limited efficacy of gemcitabine,fluorouracil,platinum chemotherapy in advanced pancreatic cancer,nab-paclitaxel,erlotinib and nimotuzumab are still in clinical trials.Therefore,it is necessary to seek new targets and treatments.In this review,we will discuss the medical treatment of advanced pancreatic cancer.
Keywords:pancreatic cancer  chemotherapy  targeted therapy
本文献已被 万方数据 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号